Clinical Trial Update: A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of BMS-986500 as monotherapy or in combination for advanced solid tumors, including advanced breast cancer and advanced ovarian cancer, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• BMS-986500

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Solid Tumor, Advanced Breast Cancer | Phase 1 | Status: RECRUITING